{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T10:15:44Z","timestamp":1648808144179},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.rmr.2010.03.015","type":"journal-article","created":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T08:37:31Z","timestamp":1272530251000},"page":"449-456","source":"Crossref","is-referenced-by-count":1,"title":["Int\u00e9r\u00eat de l\u2019association ceftazidime et aztr\u00e9onam dans les exacerbations de mucoviscidose \u00e0 Pseudomonas aeruginosa multir\u00e9sistant"],"prefix":"10.1016","volume":"27","author":[{"given":"A.","family":"Pr\u00e9votat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Wallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Wallaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2010.03.015_bib1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2010.03.015_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(03)12567-6","article-title":"Cystic fibrosis","volume":"361","author":"Ratjen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2010.03.015_bib3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0399-077X(02)00413-4","article-title":"An update on inhaled antibiotherapy in Pseudomonas aeruginosa respiratory tract infections","volume":"32","author":"Aubron","year":"2002","journal-title":"Med et Mal Inf"},{"key":"10.1016\/j.rmr.2010.03.015_bib4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1034\/j.1399-3003.2000.16d30.x","article-title":"Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus","volume":"16","author":"Doring","year":"2000","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.rmr.2010.03.015_bib5","first-page":"S57","article-title":"Crit\u00e8res cliniques de l\u2019infection \u00e0 Staphylococcus aureus et au Pseudomonas aeruginosa","volume":"20","author":"Bremont","year":"2003","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2010.03.015_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/AAC.34.3.487","article-title":"In vitro activities of combinations of aztreonam, ciprofloxacin, and ceftazidime against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from patients with cystic fibrosis","volume":"34","author":"Bosso","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.rmr.2010.03.015_bib7","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/AAC.42.7.1610","article-title":"Cefepime-aztreonam: a unique double \u03b2-lactam combination for Pseudomonas aeruginosa","volume":"42","author":"Lister","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.rmr.2010.03.015_bib8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jac\/dkg478","article-title":"In vitro effect of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa","volume":"52","author":"Oie","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.rmr.2010.03.015_bib9","first-page":"1","article-title":"Microbiology and infectious disease in cystic fibrosis","volume":"V","author":"Cystic Fibrosis","year":"1994"},{"key":"10.1016\/j.rmr.2010.03.015_bib10","doi-asserted-by":"crossref","first-page":"381s","DOI":"10.1016\/S0929-693X(03)90000-5","article-title":"Management of patients (children and adults) with cystic fibrosis","volume":"3","author":"Marguet","year":"2003","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.rmr.2010.03.015_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(89)90561-8","article-title":"Continuous infusion of ceftazidime in cystic fibrosis","volume":"2","author":"Kuzemko","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2010.03.015_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jac\/40.1.125","article-title":"Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokinetics","volume":"40","author":"Vinks","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.rmr.2010.03.015_bib13","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0140-6736(89)90164-5","article-title":"Continuous infusion of ceftazidime in cystic fibrosis","volume":"1","author":"David","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2010.03.015_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jac\/41.3.407","article-title":"Treatment of Pseudomonas \u00e6ruginosa lung infection in cystic fibrosis with high or conventional doses of ceftazidime","volume":"41","author":"De Boeck","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.rmr.2010.03.015_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00006454-198704000-00010","article-title":"Efficacy of aztreonam in pulmonary exacerbations of cystic fibrosis","volume":"6","author":"Bosso","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.rmr.2010.03.015_bib16","doi-asserted-by":"crossref","first-page":"S594","DOI":"10.1093\/clinids\/13.Supplement_7.S594","article-title":"Safety of aztreonam in patients with cystic fibrosis and allergy to beta-lactam antibiotics","volume":"13","author":"Jensen","year":"1991","journal-title":"Rev Infect Dis"},{"issue":"2","key":"10.1016\/j.rmr.2010.03.015_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/00365549209052615","article-title":"A comparison of aztreonam and ceftazidime in the treatment of respiratory infections in adults with cystic fibrosis","volume":"24","author":"Sahl","year":"1992","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.rmr.2010.03.015_bib18","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1378\/chest.123.5.1495","article-title":"Susceptibility testing of Pseudomonas \u00e6ruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis","volume":"123","author":"Smith","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2010.03.015_bib19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.medmal.2007.02.008","article-title":"Pseudomonas and bronchial disease","author":"Mayaud","year":"2007","journal-title":"Med Mal Inf"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S076184251000197X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S076184251000197X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T20:55:34Z","timestamp":1559076934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S076184251000197X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S076184251000197X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2010.03.015","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}